Rivastigmine
Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz (rivastigmine) is a small molecule pharmaceutical. Rivastigmine was first approved as Exelon on 1998-05-11. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease, dementia, and parkinson disease. The pharmaceutical is active against acetylcholinesterase and cholinesterase.
| Trade Name | Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz |
|---|---|
| Common Name | Rivastigmine |
| Indication | alzheimer disease, dementia, parkinson disease |
| Drug Class | Cholinesterase inhibitors (physostigmine type) |
